March 26, 2025 - 10:36
Cambridge, MA - BioMed Realty, a prominent player in life science real estate and part of the Blackstone portfolio, has announced its acquisition of a majority interest in the 75 Broadway project. This significant development is set to become the new global headquarters for Biogen, a leading biotechnology company.
The 75 Broadway site is strategically located in the heart of Cambridge, an area renowned for its concentration of life sciences firms and research institutions. This acquisition not only underscores BioMed Realty's commitment to supporting the life sciences sector but also highlights the growing demand for state-of-the-art facilities that cater to the unique needs of biotech companies.
Biogen's move to 75 Broadway is expected to foster innovation and collaboration within the life sciences community, further solidifying Cambridge's status as a hub for biotechnology advancement. The new headquarters will provide Biogen with the necessary infrastructure to enhance its research and development capabilities as it continues to focus on addressing serious neurological diseases.
